Within this review, several agents with potential activity against aberrant p53 signaling have been considered, as a novel approach to finding an effective targeted therapy for triple negative breast cancer
Targeting triple negative breast cancer: is p53 the answer? / Turner N, Moretti E, Siclari O, Migliaccio I, Santarpia L, D'Incalci M, Piccolo S, Veronesi A, Zambelli A, Del Sal G, Di Leo A. - In: CANCER TREATMENT REVIEWS. - ISSN 0305-7372. - ELETTRONICO. - (2013), pp. 541-550.
Targeting triple negative breast cancer: is p53 the answer?
MORETTI, ERICA;
2013
Abstract
Within this review, several agents with potential activity against aberrant p53 signaling have been considered, as a novel approach to finding an effective targeted therapy for triple negative breast cancer
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
